Description: Panelists at this session of the SOA 1998 New York Annual Meeting discuss the recent history , the current environment and issues, and the future trends of medical reinsurance, including stop-loss and special risk insurance.

Description: Medical Insurance in Latin America: Lessons Learned. Issue No. 42.

Description: Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are being cured. These are great for individuals and society, but the treatment costs are expensive which is bad for payers and reinsurers. This article explores ways for health reinsurance actuaries to participate in the space and evaluate the risk associated with these treatments

Description: This article attempts to make a modest contribution to the dialogue on the potential and risks associated with novel treatments such as cell & gene therapies. With a fast-expanding roster of what are believed to be one-time treatments at ever increasing price points aimed at curing a wider swatch of the population, they are as much a source of relief for patients stuck in medical limbo, as they are a source of anxiety for payers.

Description: With the medical insurance market experiencing health care inflation of 10 to 13 percent and medical costs averaging above $8,000 per year per employee less for single employees and more for employees with families, employers are looking at alternative options. Politicians and regulators are as well.

Description: Medical Insurance in Latin America: Lessons Learned by Jeffrey D. Miller from Health Section News, January 2002, Issue No. 42.

Description: Feature article discussing the impact of health care reform on the direct insurance market and the reinsurance market.

Description: The discussion will review major elements of the reinsurance market as health care reform replaces traditional markets. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: To inform and educate stakeholders for health plans and insurers on novel ways to optimize reinsurance structures to meet capital related goals and boost RBC and liquidity ratios. In lieu of traditional market-based financial instruments involving equity and/or debt, a quota share transaction can be used with potentially far more attractive terms and achieving essentially the same result.

Description: At this presentation from Session 81PD of the SOA 1996 Colorado Springs Meeting, the panelists examine current issues involving small-employer health reinsurance programs from viewpoints of both the direct writer and the reinsurer. From the Record of the Society of Actuaries, Vol. 22, No. 2.